Macy's (M) Rises Higher Than Market: Key Facts

Macy's (M) recently outperformed broader market indices and its sector, closing up 2.18% at $12.21 and showing an 8.14% gain prior to the latest session. However, consensus estimates project significant year-over-year declines for the upcoming quarter, with EPS forecasted at $0.18 (down 66.04%) and revenue at $4.74 billion (down 4.03%), alongside substantial full-year reductions. Despite this challenging earnings outlook, Macy's trades at a Forward P/E of 6.7, a considerable discount to its industry average of 15.47, and maintains a Zacks Rank #3 (Hold), with its industry favorably positioned in the top 14%.

Analysis

Macy's (M) presents a conflicting profile for investors, characterized by strong recent stock performance juxtaposed with a deteriorating fundamental outlook. The stock's recent 8.14% gain has outpaced both the S&P 500 and its own sector, culminating in a +2.18% move in the last session. However, this positive momentum runs contrary to forward-looking consensus estimates, which project a severe 66.04% year-over-year decline in quarterly EPS to $0.18 and a 4.03% drop in revenue to $4.74 billion. This negative trend is expected to persist for the full fiscal year, with forecasts indicating a 32.58% contraction in earnings and a 4.57% decrease in revenue. Despite this, the stock trades at a discounted Forward P/E ratio of 6.7, significantly below the industry average of 15.47, suggesting the market has priced in considerable weakness. The neutral Zacks Rank of #3 (Hold) and stagnant analyst EPS projections over the past month reinforce a cautious stance, even as the company's industry ranks favorably in the top 14% of its peers.

Key Decisions for Investors

• Investors should view the upcoming earnings release as a critical catalyst, given the consensus forecast for a significant 66.04% year-over-year decline in EPS and a 4.03% drop in revenue.
• The stock's low Forward P/E of 6.7 should be weighed carefully against the sharply negative growth forecasts, which indicates a potential value trap if the company fails to outperform these weak expectations.
• Despite the stock's recent outperformance, the lack of positive analyst estimate revisions suggests the rally is not supported by improving fundamental expectations, warranting a cautious or neutral stance.
• Consider the stock's position within a strongly-ranked industry (top 14%) as a potential mitigating factor, but prioritize the company-specific earnings data for decision-making.